Vnitr Lek 1992, 38(7):685-692

[Immunotyping of medullary and circulatory cells for prognostic evaluation of plasmacytoma].

A Sakalová, D Holománová, M Mikulecký, M Mistrík, M Steruská, T Lipsic, I Chabronová, M Prümmerová, S Gazová, M Benzová
Subkatedra hematológie a transfuziológie Institútu pre d'alsie vzdelávanie pracovníkov v zdravotníctve, Klinika hematológie a transfuziológie Fakultnej nemocnice Bratislava.

The authors discuss the prognostic impact of immunophenotyping of circulating lymphoplasmatic cells in the peripheral blood stream in patients with generalized plasmocytoma. From a group of 250 patients followed up from 1981 to 1991 they selected a sub-group of 70 patients where they evaluated in 1986-1991 after six-month intervals the phenotype of medullary and circulating cells. They used the method of immunofluorescent detection of the presence of cytoplasmic Ig, the kappa-lambda index and phenotyping of antigens CD 9, CD 10, CD 20, CD 38, HLA-DR by monoclonal antibodies. In a longitudinal investigation of the survival period they revealed that the finding of circulating cells with signs of non-differentiation (presence of antigen CD 10 detected by antibody CALLA, presence of antigens B 1 (CD 20), CD 9 on circulating lymphocytes) has a prognostic meaning suggesting shorter survival. There was a direct correlation between the increase of CALLA positive cells and CD 9 positive cells. The authors found also that release of the clonus with signs of immaturity was present when the disease developed into the aggressive stage. While the group of 250 patients had according to statistical analyses, when treated according to protocol VMCP/MOCCA, a median survival of 90 months, the median survival of the aggressive stage (with the plasmoblast and lymphoplasmocytic type resp.) was only 12 months. The authors emphasize the prognostic importance of immunological typing of heterogeneous plasmocytoma populations.

Keywords: Adult; Aged; Bone Marrow, immunology, ; Female; Humans; Immunophenotyping; Lymphocyte Subsets; Male; Middle Aged; Multiple Myeloma, diagnosis, ; Plasmacytoma, diagnosis, ; Prognosis

Published: July 1, 1992  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sakalová A, Holománová D, Mikulecký M, Mistrík M, Steruská M, Lipsic T, et al.. [Immunotyping of medullary and circulatory cells for prognostic evaluation of plasmacytoma]. Vnitr Lek. 1992;38(7):685-692.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.